89 related articles for article (PubMed ID: 8360826)
21. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
[TBL] [Abstract][Full Text] [Related]
22. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
Passerini N; Craig DQ
J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
[TBL] [Abstract][Full Text] [Related]
23. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
24. Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.
Mondon K; Zeisser-Labouèbe M; Gurny R; Möller M
Eur J Pharm Biopharm; 2011 Jan; 77(1):56-65. PubMed ID: 20888909
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G.
Erdemli Ö; Usanmaz A; Keskin D; Tezcaner A
Colloids Surf B Biointerfaces; 2014 May; 117():487-96. PubMed ID: 24530344
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
27. Stability of cyclosporine-loaded poly-sigma-caprolactone nanoparticles.
Molpeceres J; Aberturas MR; Chacón M; Berges L; Guzmán M
J Microencapsul; 1997; 14(6):777-87. PubMed ID: 9394259
[TBL] [Abstract][Full Text] [Related]
28. Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles.
das Neves J; Amiji M; Bahia MF; Sarmento B
Int J Pharm; 2013 Nov; 456(2):307-14. PubMed ID: 24012910
[TBL] [Abstract][Full Text] [Related]
29. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
Aliabadi HM; Brocks DR; Lavasanifar A
Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
[TBL] [Abstract][Full Text] [Related]
30. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation.
Alvarez-Trabado J; López-García A; Martín-Pastor M; Diebold Y; Sanchez A
Int J Pharm; 2018 Jul; 546(1-2):20-30. PubMed ID: 29753904
[TBL] [Abstract][Full Text] [Related]
31. Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.
Hermans K; Van den Plas D; Everaert A; Weyenberg W; Ludwig A
Eur J Pharm Biopharm; 2012 Sep; 82(1):27-35. PubMed ID: 22634236
[TBL] [Abstract][Full Text] [Related]
32. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.
Wang K; Qi J; Weng T; Tian Z; Lu Y; Hu K; Yin Z; Wu W
Int J Nanomedicine; 2014; 9():4991-9. PubMed ID: 25378925
[TBL] [Abstract][Full Text] [Related]
34. Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application.
Pehlivan SB; Yavuz B; Çalamak S; Ulubayram K; Kaffashi A; Vural İ; Çakmak HB; Durgun ME; Denkbaş EB; Ünlü N
J Pharm Sci; 2015 May; 104(5):1709-20. PubMed ID: 25716582
[TBL] [Abstract][Full Text] [Related]
35. Preparation of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles by a microchannel technology.
Guo F; Guo D; Zhang W; Yan Q; Yang Y; Hong W; Yang G
Eur J Pharm Sci; 2017 Mar; 99():328-336. PubMed ID: 28062259
[TBL] [Abstract][Full Text] [Related]
36. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
37. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
[TBL] [Abstract][Full Text] [Related]
38. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
Shenoy D; Little S; Langer R; Amiji M
Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
[TBL] [Abstract][Full Text] [Related]
39. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy.
Alemrayat B; Elhissi A; Younes HM
Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
